Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis

Autor: Kaltsa, G., Bamias, G., Siakavellas, S. I., Goukos, D., Dimitrios Karagiannakis, Zampeli, E., Vlachogiannakos, J., Michopoulos, S., Vafiadi, I., Daikos, G. L., Ladas, S. D.

Publikováno v: Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology
Scopus-Elsevier

Background Bacterial translocation (BT) commonly occurs in cirrhosis. Reliable biomarkers for BT are currently lacking. Human beta defensin-1 (hBD-1) is a member of the family of natural antimicrobial peptides produced by epithelial cells and partici

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7239b06f5563bed84c3530440df1cec3
http://europepmc.org/articles/PMC4700849

Review of T Helper 2-Type Inflammatory Diseases Following Immune Checkpoint Inhibitor Treatment.

Autor: Mima, Yoshihito, Ohtsuka, Tsutomu, Ebato, Ippei, Nakata, Yukihiro, Tsujita, Akihiro, Nakazato, Yoshimasa, Norimatsu, Yuta

Publikováno v: Biomedicines; Aug2024, Vol. 12 Issue 8, p1886, 16p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Host-pathobiont interactions in Crohn's disease.

Autor: Caruso R; Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA. rocaruso@med.umich.edu., Lo BC; Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA., Chen GY; Department of Internal Medicine and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA., Núñez G; Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA. gabriel.nunez@umich.edu.

Publikováno v: Nature reviews. Gastroenterology & hepatology [Nat Rev Gastroenterol Hepatol] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.

Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel disease (enroll-ex study).

Autor: Alrashed, Fatema, Abdullah, Israa, Alfadhli, Ahmad, Shehab, Mohammad

Publikováno v: Frontiers in Pharmacology; 2023, p1-9, 9p